A specialist position, used throughout the game. The wicket-keeper is the only player in the fielding side allowed to wear gloves and external leg guards, under Law 40. Wicket-keeper-batsman
a wicket-keeper who is also a very good batsman, capable of opening the batting or making good scores in the top order. Wicket maiden
a maiden over in which the bowler also dismisses a batsman. A double wicket maiden if two wickets are taken, and so on. Wicket-to-wicket (or stump-to-stump)
an imaginary line connecting the two wickets, also a style of straight, un-varied bowling. Wickets in hand
The number of wickets remaining in the innings for the batting side. For example, a team which has lost four of its ten wickets is said to have six wickets in hand. Wide
a delivery that passes illegally wide of the wicket, scoring an extra for the batting side. A wide does not count as one of the six valid deliveries that must be made in each over – an extra ball must be bowled for each wide. Wisden
Wisden Cricketers Almanack, or simply Wisden, colloquially the (Yellow) Bible of Cricket, is a cricket reference book published annually since 1864 in the UK. In 1998 an Australian and in 2012 an Indian edition was launched. Womens cricket
Cricket played between teams consisting solely of women. First recorded in 1745, it was administered separately from mens cricket until 2005. There are almost no differences in the rules.
Negative inotropes improve LV obstruction by decreasing LV ejection acceleration and hydrodynamic forces on the mitral valve. Disopyramides particular efficacy is due to its potent negative inotropic effects; in head-to-head comparison, it is more effective for gradient reduction than either beta-blocker or verapamil. Disopyramide is most often administered with beta-blockade. When used in patients resistant to beta-blockade, disopyramide is effective in 60% of cases, reducing symptoms and gradient to the extent that invasive procedures such as surgical septal myectomy are not required.Disopyramide, despite its efficacy, has one main side effect that has limited its use in the US, though it has seen wider application in Canada, UK and Japan. Vagal blockade predictably causes dry mouth, and in men with prostatism, may cause urinary retention. Teichman et al. showed that pyridostigmine used in combination with disopyramide substantially alleviates vagolytic side effects without compromising antiarrhythmic efficacy. This combination has also been shown to be effective and safe in obstructive HCM in a large cohort of patients. Some clinicians prescribe pyridostigmine sustained release (marketed in the US as Mestinon Timespan) to every patient begun on disopyramide. This combination increases acceptance of higher disopyramide dosing, important since there is a dose-response correlation in obstructive HCM, higher doses yielding lower gradients. Another concern about disopyramide has been the hypothetical potential for inducing sudden death from its type 1 anti-arrhythmic effects.